Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The anti‐tumor activity of anti‐PD‐1 therapy in previously untreated Chinese squamous NSCLC patients will be investigated in this clinical trial.
Epistemonikos ID: 8010c3fede350f4fe56cd99b2412fe6a65dcf023
First added on: May 21, 2024